Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reward | 19 | 2025 | 209 | 5.490 |
Why?
|
| Cocaine-Related Disorders | 9 | 2025 | 40 | 5.030 |
Why?
|
| Motivation | 15 | 2025 | 310 | 3.130 |
Why?
|
| Anhedonia | 7 | 2024 | 13 | 2.980 |
Why?
|
| Substance-Related Disorders | 14 | 2024 | 441 | 2.850 |
Why?
|
| Dextroamphetamine | 8 | 2021 | 108 | 2.590 |
Why?
|
| Cocaine | 5 | 2024 | 79 | 2.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2025 | 125 | 1.810 |
Why?
|
| Emotions | 8 | 2021 | 372 | 1.790 |
Why?
|
| Central Nervous System Stimulants | 5 | 2021 | 233 | 1.740 |
Why?
|
| Hallucinogens | 5 | 2022 | 83 | 1.570 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 7 | 2020 | 74 | 1.290 |
Why?
|
| Decision Making | 7 | 2022 | 674 | 1.280 |
Why?
|
| Behavior Therapy | 2 | 2024 | 93 | 1.260 |
Why?
|
| Stress, Psychological | 6 | 2025 | 342 | 1.210 |
Why?
|
| Adult | 49 | 2025 | 27918 | 1.200 |
Why?
|
| Social Behavior | 6 | 2014 | 307 | 1.170 |
Why?
|
| Double-Blind Method | 18 | 2022 | 1729 | 1.140 |
Why?
|
| Naltrexone | 2 | 2022 | 139 | 1.110 |
Why?
|
| Dopamine | 3 | 2022 | 276 | 1.070 |
Why?
|
| Neuropsychological Tests | 6 | 2020 | 543 | 1.050 |
Why?
|
| Young Adult | 25 | 2025 | 6930 | 1.020 |
Why?
|
| Depression | 3 | 2020 | 544 | 0.970 |
Why?
|
| Alcohol Drinking | 4 | 2025 | 283 | 0.950 |
Why?
|
| Cognition | 3 | 2020 | 627 | 0.920 |
Why?
|
| Thinking | 1 | 2025 | 39 | 0.870 |
Why?
|
| Heart Rate | 10 | 2020 | 505 | 0.870 |
Why?
|
| Psychomotor Performance | 8 | 2022 | 497 | 0.860 |
Why?
|
| Anger | 2 | 2024 | 80 | 0.850 |
Why?
|
| Nicotine | 4 | 2022 | 208 | 0.840 |
Why?
|
| Female | 52 | 2025 | 48702 | 0.810 |
Why?
|
| Male | 51 | 2025 | 44557 | 0.810 |
Why?
|
| Inflammation | 2 | 2020 | 1050 | 0.800 |
Why?
|
| Healthy Volunteers | 4 | 2018 | 148 | 0.800 |
Why?
|
| Memory, Short-Term | 3 | 2018 | 242 | 0.790 |
Why?
|
| Affect | 8 | 2023 | 396 | 0.750 |
Why?
|
| Humans | 63 | 2025 | 93515 | 0.740 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2013 | 68 | 0.730 |
Why?
|
| Tobacco Use Disorder | 4 | 2024 | 121 | 0.700 |
Why?
|
| Adolescent | 22 | 2024 | 9606 | 0.700 |
Why?
|
| Cannabis | 1 | 2022 | 38 | 0.690 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2011 | 43 | 0.690 |
Why?
|
| Pleasure | 4 | 2023 | 14 | 0.650 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2021 | 1914 | 0.630 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 97 | 0.620 |
Why?
|
| Intelligence | 2 | 2018 | 67 | 0.620 |
Why?
|
| Dronabinol | 2 | 2022 | 58 | 0.600 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 18 | 0.580 |
Why?
|
| Alcoholism | 3 | 2025 | 188 | 0.560 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 147 | 0.550 |
Why?
|
| Appetitive Behavior | 1 | 2018 | 14 | 0.550 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 38 | 0.540 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 68 | 0.530 |
Why?
|
| Cues | 6 | 2022 | 186 | 0.520 |
Why?
|
| Smoking | 7 | 2012 | 648 | 0.510 |
Why?
|
| Schizophrenia | 1 | 2020 | 529 | 0.500 |
Why?
|
| Middle Aged | 21 | 2025 | 27573 | 0.500 |
Why?
|
| Cytokines | 1 | 2020 | 863 | 0.490 |
Why?
|
| Levodopa | 1 | 2016 | 36 | 0.490 |
Why?
|
| Dopamine Agents | 1 | 2016 | 32 | 0.490 |
Why?
|
| Facial Recognition | 1 | 2016 | 17 | 0.470 |
Why?
|
| Speech | 2 | 2020 | 90 | 0.470 |
Why?
|
| Motor Activity | 1 | 2018 | 323 | 0.470 |
Why?
|
| Drug Tolerance | 1 | 2015 | 59 | 0.460 |
Why?
|
| Ethanol | 2 | 2015 | 273 | 0.450 |
Why?
|
| Social Perception | 1 | 2016 | 92 | 0.450 |
Why?
|
| Attention | 2 | 2018 | 411 | 0.440 |
Why?
|
| Exercise | 1 | 2018 | 353 | 0.440 |
Why?
|
| Euphoria | 2 | 2011 | 47 | 0.430 |
Why?
|
| Photic Stimulation | 5 | 2018 | 509 | 0.420 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 170 | 0.420 |
Why?
|
| Oxycodone | 1 | 2014 | 35 | 0.410 |
Why?
|
| Craving | 3 | 2025 | 24 | 0.410 |
Why?
|
| Mindfulness | 2 | 2025 | 19 | 0.400 |
Why?
|
| Frontal Lobe | 1 | 2014 | 126 | 0.400 |
Why?
|
| Basal Ganglia | 1 | 2013 | 46 | 0.390 |
Why?
|
| Blood Pressure | 6 | 2016 | 896 | 0.390 |
Why?
|
| Firefighters | 2 | 2023 | 2 | 0.380 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 177 | 0.380 |
Why?
|
| Amygdala | 1 | 2013 | 86 | 0.380 |
Why?
|
| Trust | 1 | 2013 | 97 | 0.370 |
Why?
|
| Empathy | 1 | 2014 | 150 | 0.360 |
Why?
|
| Verbal Behavior | 1 | 2012 | 33 | 0.360 |
Why?
|
| Marijuana Abuse | 3 | 2025 | 29 | 0.360 |
Why?
|
| Executive Function | 1 | 2012 | 103 | 0.360 |
Why?
|
| Genotype | 3 | 2013 | 1866 | 0.360 |
Why?
|
| Facial Expression | 1 | 2012 | 58 | 0.350 |
Why?
|
| Caffeine | 1 | 2012 | 85 | 0.350 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 300 | 0.340 |
Why?
|
| Amphetamine | 1 | 2012 | 101 | 0.340 |
Why?
|
| Unsafe Sex | 1 | 2010 | 45 | 0.310 |
Why?
|
| Affective Symptoms | 1 | 2010 | 56 | 0.310 |
Why?
|
| Psychological Tests | 3 | 2016 | 88 | 0.300 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 513 | 0.300 |
Why?
|
| Autonomic Nervous System | 3 | 2020 | 67 | 0.290 |
Why?
|
| Language | 2 | 2020 | 158 | 0.290 |
Why?
|
| Smoking Cessation | 2 | 2011 | 269 | 0.280 |
Why?
|
| Gambling | 2 | 2010 | 168 | 0.270 |
Why?
|
| Self Report | 5 | 2022 | 328 | 0.240 |
Why?
|
| Behavior, Addictive | 2 | 2024 | 137 | 0.230 |
Why?
|
| Psychotherapy, Group | 1 | 2025 | 37 | 0.230 |
Why?
|
| Delay Discounting | 1 | 2025 | 8 | 0.230 |
Why?
|
| Time Factors | 4 | 2025 | 5410 | 0.220 |
Why?
|
| Individuality | 3 | 2016 | 114 | 0.210 |
Why?
|
| Bayes Theorem | 2 | 2023 | 402 | 0.210 |
Why?
|
| Tobacco Use | 1 | 2024 | 29 | 0.210 |
Why?
|
| HIV Infections | 2 | 2010 | 961 | 0.200 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 306 | 0.200 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2023 | 5 | 0.200 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 17 | 0.190 |
Why?
|
| Reaction Time | 3 | 2015 | 317 | 0.190 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 11 | 0.180 |
Why?
|
| Facial Muscles | 2 | 2012 | 24 | 0.180 |
Why?
|
| Recreation | 1 | 2021 | 9 | 0.170 |
Why?
|
| Comorbidity | 1 | 2025 | 1007 | 0.170 |
Why?
|
| Sex Characteristics | 3 | 2013 | 333 | 0.170 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 171 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 1917 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1713 | 0.160 |
Why?
|
| Laboratories | 1 | 2020 | 46 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2022 | 917 | 0.150 |
Why?
|
| Personality | 2 | 2011 | 140 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2020 | 82 | 0.150 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 47 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2715 | 0.140 |
Why?
|
| Surveys and Questionnaires | 4 | 2015 | 2802 | 0.140 |
Why?
|
| Galvanic Skin Response | 1 | 2018 | 12 | 0.140 |
Why?
|
| Physical Fitness | 1 | 2018 | 52 | 0.140 |
Why?
|
| Hunger | 1 | 2018 | 20 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 353 | 0.140 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1762 | 0.140 |
Why?
|
| Psychophysics | 1 | 2018 | 72 | 0.130 |
Why?
|
| Oxytocin | 2 | 2020 | 75 | 0.130 |
Why?
|
| Adolescent Behavior | 2 | 2011 | 111 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 2484 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1847 | 0.130 |
Why?
|
| Arousal | 1 | 2018 | 171 | 0.130 |
Why?
|
| Electromyography | 1 | 2018 | 198 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 502 | 0.130 |
Why?
|
| Aged | 4 | 2024 | 20434 | 0.130 |
Why?
|
| Social Environment | 1 | 2018 | 194 | 0.130 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 10 | 0.120 |
Why?
|
| Games, Experimental | 2 | 2013 | 11 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2018 | 494 | 0.120 |
Why?
|
| Attentional Bias | 1 | 2015 | 10 | 0.120 |
Why?
|
| Drug Users | 1 | 2015 | 29 | 0.110 |
Why?
|
| Personality Inventory | 1 | 2015 | 111 | 0.110 |
Why?
|
| Machine Learning | 1 | 2018 | 341 | 0.110 |
Why?
|
| Computational Biology | 1 | 2018 | 578 | 0.110 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2014 | 7 | 0.110 |
Why?
|
| Respiratory Sinus Arrhythmia | 1 | 2014 | 2 | 0.110 |
Why?
|
| Gene Expression | 1 | 2018 | 1301 | 0.110 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 290 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1931 | 0.100 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 32 | 0.100 |
Why?
|
| Signal Detection, Psychological | 1 | 2013 | 19 | 0.100 |
Why?
|
| Animals | 2 | 2024 | 28155 | 0.100 |
Why?
|
| Hydrocortisone | 2 | 2012 | 296 | 0.100 |
Why?
|
| United States | 2 | 2024 | 7622 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1723 | 0.090 |
Why?
|
| Homozygote | 1 | 2012 | 207 | 0.090 |
Why?
|
| Sensory Thresholds | 1 | 2012 | 51 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3476 | 0.090 |
Why?
|
| Word Association Tests | 1 | 2011 | 5 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 203 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 180 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2012 | 297 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2014 | 569 | 0.080 |
Why?
|
| Writing | 1 | 2011 | 29 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2011 | 115 | 0.080 |
Why?
|
| Probability | 1 | 2011 | 355 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2011 | 164 | 0.080 |
Why?
|
| Pattern Recognition, Visual | 1 | 2012 | 158 | 0.080 |
Why?
|
| Visual Perception | 1 | 2014 | 334 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2011 | 53 | 0.080 |
Why?
|
| Stroop Test | 1 | 2010 | 11 | 0.080 |
Why?
|
| Intelligence Tests | 1 | 2010 | 38 | 0.080 |
Why?
|
| HIV Seropositivity | 1 | 2010 | 50 | 0.080 |
Why?
|
| Saliva | 1 | 2011 | 124 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2010 | 239 | 0.080 |
Why?
|
| Alleles | 1 | 2013 | 1139 | 0.080 |
Why?
|
| Memory | 1 | 2011 | 227 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 367 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 224 | 0.070 |
Why?
|
| DNA Repeat Expansion | 1 | 2007 | 5 | 0.070 |
Why?
|
| Placebos | 3 | 2013 | 206 | 0.070 |
Why?
|
| Anxiety | 1 | 2010 | 337 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1190 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 624 | 0.070 |
Why?
|
| Communication | 1 | 2011 | 434 | 0.070 |
Why?
|
| Ataxia | 1 | 2007 | 46 | 0.070 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 140 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 73 | 0.060 |
Why?
|
| Object Attachment | 1 | 2006 | 20 | 0.060 |
Why?
|
| Learning | 1 | 2009 | 293 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2013 | 3054 | 0.060 |
Why?
|
| Universities | 1 | 2006 | 150 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 2441 | 0.060 |
Why?
|
| Students | 1 | 2006 | 179 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2025 | 9099 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2018 | 493 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 740 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 390 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 170 | 0.040 |
Why?
|
| Breath Tests | 2 | 2011 | 58 | 0.040 |
Why?
|
| Smokers | 1 | 2021 | 54 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 437 | 0.040 |
Why?
|
| Psycholinguistics | 1 | 2020 | 10 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2016 | 884 | 0.040 |
Why?
|
| Self Concept | 2 | 2013 | 136 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2021 | 194 | 0.040 |
Why?
|
| Semantics | 1 | 2020 | 55 | 0.040 |
Why?
|
| Biomarkers | 2 | 2019 | 1910 | 0.040 |
Why?
|
| Carbon Monoxide | 2 | 2010 | 98 | 0.030 |
Why?
|
| Heart | 1 | 2020 | 522 | 0.030 |
Why?
|
| Urban Population | 1 | 2018 | 234 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 193 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 71 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 167 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 382 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2012 | 8 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2012 | 46 | 0.020 |
Why?
|
| Linear Models | 1 | 2014 | 413 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2014 | 159 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 2391 | 0.020 |
Why?
|
| Introns | 1 | 2012 | 300 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 4560 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 775 | 0.020 |
Why?
|
| Forecasting | 1 | 2011 | 293 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 37 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1161 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 228 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 970 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1531 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 543 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 829 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 2544 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 961 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 700 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2006 | 217 | 0.010 |
Why?
|
| Chicago | 1 | 2006 | 1464 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5899 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 7061 | 0.010 |
Why?
|